Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tutik Hardjianti"'
Autor:
Nurmila Nurmila, Wasis Udaya, Agus Sudarso, Syakib Bakri, Haerani Rasyid, Hasyim Kasim, Tutik Hardjianti, Arifin Seweng
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 10:2065-2069
Frailty is an age-related biological syndrome characterized by a decrease in physiological capacity and stress resistance as a result of a gradual decline in the body's physiological systems. Frailty syndrome is categorized into three categories: rob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f81e67727a9125dfa9e1c639ace9f60a
https://doi.org/10.3889/oamjms.2022.10414
https://doi.org/10.3889/oamjms.2022.10414
Autor:
Fahrul Abdul Azis, Tutik Hardjianti, Andi Fachruddin Benyamin, Sahyuddin Saleh, Rahmawati Minhajat, Dimas Bayu
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 10:285-289
INTRODUCTION: Coagulation factor deficit is a very uncommon hemostatic condition in which a single component or numerous factors are lacking. Hereditary coagulation factor defects are autosomal recessive, meaning that they can affect both men and wom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64ccdf3eebdf9f0e779c752459575f54
https://doi.org/10.3889/oamjms.2022.9920
https://doi.org/10.3889/oamjms.2022.9920
Autor:
Soraya Wildhani Jamil, Muhammad Ilyas, Nur Ahmad, Syakib Bakri, Tutik Hardjianti, Muhammad Lutfi Parewangi, Arifin Seweng
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 10:1097-1101
Background: Coronavirus disease 2019 (COVID-19) is a viral pneumonia infection that spreads rapidly globally (with a number of cases > 15,000,000 worldwide and mortality of ±4%) until it is designated a pandemic by the World Health Organization (WHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecc4c546203c840274c01236bd4958e7
https://doi.org/10.3889/oamjms.2022.9109
https://doi.org/10.3889/oamjms.2022.9109
Autor:
Erwin Arief, Fidiyah Rusdi, Harun Iskandar, Tutik Hardjianti, Hasyim Kasim, Syakib Bakri, Wasis Udaya, Arifin Seweng
Publikováno v:
Enfermería Clínica. 30:456-460
Background Adenocarcinoma is the most common of lung Cancer. The treatment for early stage of lung Adenocarcinoma (I, II) is surgery. Targeted therapy is given to lung Adenocarcinoma patients with EGFR-TKI mutations. Chemotherapy is given to lung Ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef6475150e6bf55581d007603e6b8885
https://doi.org/10.1016/j.enfcli.2019.10.120
https://doi.org/10.1016/j.enfcli.2019.10.120